This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The Heart Rhythm Society (HRS) is preparing for HRX 2024, the third annual event of its kind, which will be held from September 5-7, 2024, in Atlanta, GA, gathering cardiovascular health innovators together to explore discoveries and advance partnerships between medicine and technology. On Thursday, Sept.
recently announced that Digitiva, a non-invasive digital health solution for heartfailure management, has been listed with the U.S. a smartphone app designed for heartfailure patients and built on the Welldoc, Inc. a smartphone app designed for heartfailure patients and built on the Welldoc, Inc.
PPMC, part of the University of Pennsylvania Health System, renowned for advanced clinical research, innovation, and compassionate patient care, stands at the forefront as the first in the Northeast United States to offer the Genesis System. Genesis is the latest advancement in Robotic Magnetic Navigation technology.
IntroductionVentricular assist devices (VADs) are lifesavers for people with advanced heartfailure. These data are crucial for driving innovation in this field and for improving the lives of patients who depend on VADs.
FIRE1s Norm heartfailure management system offers a unique approach for patients to manage heartfailure. The company also announced Ellie McGuire, Partner at Polaris Partners, and Michael Wasserman, Partner and COO at Elevage Medical Technologies have joined its Board of Directors.
Additionally, the algorithm demonstrated its ability to pinpoint specific, clinically relevant segments of heart sound recordings, offering a transparent and explainable AI approach that aligns with physicians diagnostic workflows. The companys goal is to develop pioneering AI solutions that address significant gaps in healthcare delivery.
It is exciting to see the convergence of our pioneering work in artificial intelligence and remote patient monitoring through this new partnership between Anumana and InfoBionic.Ai,” said Peter Noseworthy, MD, chair of the Heart Rhythm Services Division of Cardiovascular Medicine at Mayo and a board director at InfoBionic.Ai. “By
The robotic technology represented an entirely novel way to address heart rhythm disorders in a minimally invasive procedure with the benefits of robotic precision and safety. When left untreated, arrhythmias may significantly increase the risk of stroke, heartfailure, and sudden cardiac arrest.
Luigi Caliendo explains the benefits of Robotic Technology to President Vincenzo de Luca. Luigi Caliendo explains the benefits of Robotic Technology to President Vincenzo de Luca. When left untreated, arrhythmias may significantly increase the risk of stroke , heartfailure , and sudden cardiac arrest.
The retrospective analysis of data from the MODERATO II study demonstrated that AVIM therapy significantly improved echocardiographic (Echo) markers of diastolic dysfunction, an important component in the development of heartfailure, in hypertensive patients. Advanced HeartFailure Cardiologist, Duke Health on Feb.
mtaschetta-millane Tue, 07/16/2024 - 09:47 July 16, 2024 — Ultrahuman, a pioneer in wearable technology , launches PowerPlugs, a platform for individual apps and plugins built on top of Ultrahuman’s health and wellness data stack. AFib is the most common type of irregular heart rhythm or arrhythmia.
The sale enhances Edwards’ balance sheet flexibility for disciplined investments in technologies for aortic, mitral, tricuspid and pulmonic patients, as well as new therapeutic areas for interventional heartfailure. Critical Care has made significant contributions to our company and has a long history of pioneering innovation.
Early Feasibility Study (FUTURE-HF2) of its FIRE1 System for remote heartfailure monitoring. The FIRE1 System is the first device designed to directly measure a patient’s volume status by measuring the largest vein in the body where most fluid is stored – the inferior vena cava (IVC) – to better manage heartfailure.
12, 2024 Physicians have a new treatment option for many of the sickest pediatric patients with heartfailure andcardiogenic shock. and Impella CP enable heart recovery as part of the world's smallest heart pump platform. with SmartAssist tim.hodson Wed, 12/18/2024 - 14:06 Dec.
Food and Drug Administration ( FDA ) granted an Investigational Device Exemption (IDE) to initiate a US Pivotal Study with its technology. Over 100 patients have been treated with the HighLife technology within different clinical programs in the USA, Europe and APAC. Javits Convention Center, North.
Cardiac amyloidosis is a heterogeneous disease that results from the accumulation of abnormal proteins within the heart, impairing its ability to pump blood. Over time, the build-up of these proteins causes the heart muscle to stiffen, eventually leading to heartfailure, which can have dire outcomes if not found early.
Cambridge, MA-based artificial intelligence (AI)-driven health technology company, Anumana, has announced its receipt of the International Organization for Standardization (ISO) 13485 certification for its Quality Management System. ECG-AI LEF, the company’s breakthrough AI algorithm, received U.S.
Health systems leveraging Guidehealth can seamlessly integrate Story Health’s program to support at-risk patients with heart conditions like heartfailure, hypertension, and arrhythmia, providing better care while also reducing the total cost of care, according to a written statement detailing the deal.
milla1cf Tue, 05/21/2024 - 08:00 May 21, 2024 — Stereotaxis , a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has been invited to present at HRS Africa Summit 2024 , scheduled to take place during Heart Rhythm Society Scientific Sessions in Boston, Massachusetts.
Lead researcher Dr Pankaj Garg , of the University of East Anglia’s Norwich Medical School and a consultant cardiologist at the Norfolk and Norwich University Hospital, heads up a team of researchers who have pioneered innovative and revolutionary 4D MRI imaging technology.
Septic cardiomyopathy, a life-threatening complication of sepsis, can cause acute heartfailure and carry a high mortality risk. Fortunately, engineered exosomes, created through bioengineering technology, may represent a potential new treatment method. Current treatments have limitations.
There, he served as an investigator in many high-profile clinical trials, including several significant structural heart studies. Dr. Shreenivas is a frequent speaker at major scientific meetings and has been widely published in peer-reviewed journals across the structural heart, heartfailure, and coronary arenas.
2, 2024 — Eko Health recently announced a new independent study from researchers at Imperial College London (Imperial) that demonstrated how AI can identify patients with significantly higher risk of experiencing major adverse cardiac events (MACE), including heart attacks and heartfailure. Nicholas S.
These innovative companies leverage AI to develop cutting-edge diagnostic tools, predictive analytics, and personalized medicine approaches. These companies are at the forefront of innovation, driving improvements in patient outcomes and reshaping the future of healthcare delivery.
Immuno-cardiology is an emerging field that explores the interplay between the immune system, inflammation and cardiovascular health/disease, aiming to develop innovative therapies for preventing and treating cardiac diseases.
The device is a patented 3-lead, 2-channel wireless continuous ECG wearable device that allows physicians the ability to address and assess sleep and heart health remotely. Peerbridge Health continues to innovate by compounding clinical utility in one simple device," said Andrea Natale, M.D., David's Medical Center.
ET Murphy Ballroom 4 Comparison of an "Inclisiran First" Strategy with Usual Care in Patients With Atherosclerotic Cardiovascular Disease: Results From the VICTORION-INITIATE Randomized Trial Targeting Weight Loss to Personalize the Prevention of Type 2 Diabetes Once-weekly Semaglutide in Patients with HeartFailure With Preserved Ejection Fraction, (..)
These technologies are not just reshaping but also empowering how cardiology practices manage operations, deliver care, and enhance patient outcomes. These technologies are reshaping how cardiology practices manage operations, deliver care, and enhance patient outcomes.
History & Future of Cardiac Remote Patient Monitoring Healthcare reforms fueled by government legislation and recent technologicalinnovations have propelled cardiac remote patient monitoring to the forefront in the early 2020s, but the history of cardiac remote patient monitoring dates to more than half a century ago.
New York Valves marks the next iteration of this legacy, featuring three days of transformative research and techniques that will redefine the landscape of structural heart interventions. From novel therapies to best clinical practices, this summit embodies the evolution of transcatheter and surgical interventions.
New York Valves marks the next iteration of this legacy, featuring three days of transformative research and techniques that will redefine the landscape of structural heart interventions. From novel therapies to best clinical practices, this summit embodies the evolution of transcatheter and surgical interventions.
healthcare providers can now detect Low EF, a key heartfailure indicator, in 15 seconds using an Eko stethoscope during a routine physical examination. This leap in early detection marks both a significant medical innovation and a new era in the detection of cardiovascular disease. Heartfailure. In the U.S.,
million Department of Defense grant awarded to the Georgia Institute of Technology (Georgia Tech), Yaxin Wang, PhD (seated left), O.H. suffer from heartfailure , and there are approximately 400,000 heart-failure-related deaths in this country each year. Through a new four-year, $7.8 Department of Veterans Affairs.
Clinical trials and innovativetechnology took center stage during the month of April, racking up some record number views. New Study Reveals 65 and Older Population Lowered Blood Pressure, Cholesterol and Weight Using Mobile Technology 2. 24: SGLT-2 Inhibitors Show Mixed Results After Heart Attack 10.
By enabling the decisive shift from a reactive to a proactive cardiology model, this technology doesnt just improve patient outcomes it is also helping keep cardiovascular care sustainable and affordable. At the heart of AIs impact on cardiology? These costs represent a massive portion of total health expenditures.
tim.hodson Mon, 03/31/2025 - 15:02 March 31, 2025 iRhythm Technologies, Inc. These findings challenge the long-held assumption that frequent symptoms justify short-duration monitoring, said Mintu Turakhia, MD, iRhythm Chief Medical and Scientific Officer and EVP of Product Innovation. Circulation: HeartFailure.
Getty Images milla1cf Thu, 06/13/2024 - 20:38 June 13, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest innovation in cardiac surgery, the Avalus Ultra valve. During this procedure, a surgeon will make an incision in the sternum to open the chest and expose the heart.
The American Heart Association funds Strategically Focused Research Networks (SFRN) as part of its mission. Research teams apply for the programs four-year grants with novel and innovative ideas to better understand cardiovascular diseases impacted by each SFRN focus, the latest of which is cardiovascular-kidney-metabolic (CKM) syndrome.
Volta Medical has announced it has entered into a Joint Development Agreement with GE Healthcare to enhance arrhythmia procedures with artificial intelligence (AI)-driven electrophysiology technologies. Volta Medical’s AI solution is designed to assist electrophysiologists in real-time assessment of dispersed electrograms (EGMs).
milla1cf Tue, 04/23/2024 - 15:53 April 23, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest innovation in cardiac surgery, the Avalus Ultra valve. When the valve narrows, it does not open or close properly, making the heart work harder to pump blood throughout the body.
mtaschetta-millane Mon, 07/29/2024 - 09:02 July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing patient care through structural heartinnovation, addressing large unmet patient needs and supporting sustainable long-term growth.
Image courtesy: Philips christine.book Wed, 06/12/2024 - 14:07 June 12, 2024 — Royal Philips has announced its next-generation AI-enabled cardiovascular ultrasound platform to help speed up cardiac ultrasound analysis with proven AI technology and reduce the burden on echocardiography labs.
reported results from a clinical study of revolutionary earbuds that use a new technology - In-ear Infrasonic Hemodynography to Detects Aortic Stenosis Murmur Before and After Transcatheter Aortic Valve Replacement (TAVR). milla1cf Tue, 12/26/2023 - 21:36 December 26, 2023 — MindMics, Inc.
This advanced imaging technology allows me and my fellow clinicians to perform complex cardiology interventions with a high level of precision and exceptional image quality,” said Sean Mazer , M.D., FHRS, FACC, electrophysiologist and president of the New Mexico Heart Institute/Lovelace Medical Group *. It’s an honor to have the U.S.’s
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content